Lonza erzielt einen Umsatz von CHF 5.4 Milliarden und einem Umsatzwachstum von 20% (kWk)1 CHF 1.7 Milliarden Kern-EBITDA resultieren in einer Marge von 30,8% 2021
WeiterlesenAutor: Firma Lonza Group Ltd.
Lonza Reports Strong 2020 Performance, Driven By Sales Growth in Pharma and Biotech Business
Lonza delivers on guidance1 with CHF 4.5 billion sales, 12.0%2 sales growth, and CHF 1.4 billion CORE EBITDA, resulting in a 31.2% margin Lonza results mainly reflect
Weiterlesen